跳至主要内容
临床试验/NL-OMON50690
NL-OMON50690已完成不适用

Promoting implementation of seizure detection devices in epilepsy care: the PROMISE study - the PROMISE study

Stichting Epilepsie Instellingen Nederland0 个研究点目标入组 2 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
2

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • Age 4-16 years
  • Diagnosis of refractory epilepsy with >=1 major nocturnal seizure per week.
  • Treated at one of the following epilepsy centers: SEIN, Kempenhaeghe or UMCU.
  • Written informed consent by legal representatives (mostly parents) and also
  • by the subject when aged >=12 years and capable of signing informed consent.

排除标准

  • Intensive non-epileptic movement patterns such as severe choreatiform
  • movements, intensive sleep walking, or frequent night terrors (> 1/week).
  • Minor motor seizures only, i.e. non-generalized or short (< 10 sec.) tonic
  • seizures or isolated myoclonias that are self-limited and do not require
  • intervention.
  • Presence of a pacemaker or cardiac arrhythmias that may generate false alarms
  • (e.g. supraventricular tachycardia).
  • Inability to comply to the trial procedure.
  • Skin characteristics (e.g. tattoo) that may affect photoplethysmography and
  • thereby influence performance of the Nightwatch .
  • Dependence on another SDD (e.g. Emfit or saturation monitor). Simultaneous
  • use of a baby phone (or other types of microphones) is permitted.
  • Subjects who are not sleeping alone in the bed (i.e. co-sleeping in the
  • parents*/guardians* bed influences the remote SDD). We do not allow subjects
  • and parents/guardians to change their sleeping habits for the duration of the
  • study only.

研究者

相似试验